AB
IMUX icon

Amalgamated Bank’s Immunic IMUX Stock Holding History

Amalgamated Bank’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-226
Closed -$26K – 3115
2022
Q1 		$26K Buy
+226
New +$26.2K ﹤0.01% 2717

Other funds holding IMUX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Amalgamated Bank's IMUX Position: Q2 2022 in Review

Amalgamated Bank sold out of Immunic (IMUX) in Q2 2022, closing a stake of 226 shares — an estimated $26K sold.

Amalgamated Bank first reported a position in IMUX in Q1 2022 and held it in 1 quarter. The position peaked at $26K in Q1 2022. 72 funds tracked by Wall St. Rank hold IMUX as of Q2 2022.

  • Amalgamated Bank reported no remaining Immunic position as of Q2 2022 after selling out during the quarter.
  • Amalgamated Bank sold 226 Immunic shares in Q2 2022, an estimated $26K.
  • Amalgamated Bank first reported a position in Immunic in Q1 2022 and held it in 1 quarter.
  • Amalgamated Bank's Immunic position peaked at $26K in Q1 2022.
  • 72 funds tracked by Wall St. Rank held Immunic as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.